Warning Letter Wednesday® Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Claims in videos are “fair game” for enforcement
Takeaway -
Warning letters show claims made in socials, blogs, testimonials & hashtags
Takeaway -
Citing ingredient research is a marketing claim
Takeaway -
There are no FDA approved supplement facilities or supplement products
Takeaway -
Companies marketing CBD products should avoid making disease claims
Takeaway -
Citing studies leads to increased scrutiny
Takeaway -
Words like “may help with” is not a get-out-of-claims-jail-free card
Takeaway -
Companies that compensate influencers or affiliates may be responsible for claims they make
Takeaway -
The FDA regulates based on intended use
Takeaway -
Find high-risk words lurking in old blogs, testimonials, and socials
Takeaway -
Plan for FDA inspections by addressing common violations
Takeaway -
Plan for inspections with an “FDA Inspection” SOP